Evidence map›Paper›PMID 30143533›Full record

ArticleThe Journal of biological chemistry2018

Glycation of type I collagen selectively targets the same helical domain lysine sites as lysyl oxidase-mediated cross-linking.

David M Hudson, Marilyn Archer, Karen B King, David R Eyre

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Glycation in the cardiomyocyte.Vitamins and hormones · 2024
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Ligament Alteration in Diabetes Mellitus.Journal of clinical medicine · 2022
    Review
  19. Review
  20. Novel regulatory roles of small leucine-rich proteoglycans in remodeling of the uterine cervix in pregnancy.Matrix biology : journal of the International Society for Matrix Biology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

David M HudsonFrom the Department of Orthopaedics and Sports Medicine, University of Washington, Seattle, Washington 98195 and dmhudson@uw.edu.ORCID 0000-0002-3253-9890
Marilyn ArcherFrom the Department of Orthopaedics and Sports Medicine, University of Washington, Seattle, Washington 98195 and.
Karen B Kingthe Department of Orthopedics, University of Colorado School of Medicine, Aurora, Colorado 80045.ORCID 0000-0002-8972-2987
David R EyreFrom the Department of Orthopaedics and Sports Medicine, University of Washington, Seattle, Washington 98195 and.ORCID 0000-0003-2605-8545
University of Washington · USUniversity of Colorado Denver · US

Funding

Project 3: Collagen post-translational modification and cross-linking in OIP01HD070394 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI LEE, BRENDAN · 2011 to 2020
$13.4M
Collagen Cross-linking in Skeletal Aging and DiseaseR37AR037318 · NIAMS · UNIVERSITY OF WASHINGTON · PI EYRE, DAVID R · 2010 to 2019
$3.4M
PATHOLOGY OF INBORN SKELETAL DISEASESR01AR037318 · NIAMS · UNIVERSITY OF WASHINGTON · PI EYRE, DAVID R · 1986 to 2009
$3.4M
NIAMS NIH HHS R01 AR037318NIAMS NIH HHS R37 AR037318NICHD NIH HHS P01 HD070394
6 · The paper itself

Abstract

Nonenzymatic glycation of collagen has long been associated with the progressive secondary complications of diabetes. How exactly such random glycations result in impaired tissues is still poorly understood. Because of the slow turnover rate of most fibrillar collagens, they are more susceptible to accumulate time-dependent glycations and subsequent advanced glycation end-products. The latter are believed to include cross-links that stiffen host tissues. However, diabetic animal models have also displayed weakened tendons with reduced stiffness. Strikingly, not a single experimentally identified specific molecular site of glycation in a collagen has been reported. Here, using targeted MS, we have identified partial fructosyl-hydroxylysine glycations at each of the helical domain cross-linking sites of type I collagen that are elevated in tissues from a diabetic mouse model. Glycation was not found at any other collagen lysine residues. Type I collagen in mouse tendons is cross-linked intermolecularly by acid-labile aldimine bonds formed by the addition of telopeptide lysine aldehydes to hydroxylysine residues at positions α1(I)Lys

Indexed as

Amino AcidsAmino Acid SequenceAnimalsBlood GlucoseCollagen Type ICross-Linking ReagentsDiabetes Mellitus, Type 2Disease Models, AnimalGlycated HemoglobinGlycation End Products, AdvancedGlycosylationHydroxylationHydroxylysineLysineMaleMass SpectrometryAmino AcidsBlood GlucoseCollagen Type ICross-Linking ReagentsGlycated HemoglobinGlycation End Products, AdvancedHydroxylysineLysineProtein-Lysine 6-Oxidasepyridinolinecollagendiabetesextracellular matrixglycationmass spectrometry (MS)post-translational modification (PTM)tendon

Identifiers

PMID30143533
PMCPMC6177574
OpenAlexW2888467384

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.